| Record ID | marc_records_scriblio_net/part22.dat:1386109:1528 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part22.dat:1386109:1528?format=raw |
LEADER: 01528cam 2200325 a 4500
001 91009498 //r93
003 DLC
005 19930614143829.0
008 910211s1991 ne a b 10110 eng c
010 $a 91009498 //r93
020 $a0444813764 (acid-free paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRM666.P87$bE77 1990
060 $aW3 EX89 no. 944$aQW 800 E79 1990c
082 00 $a615/.3$220
110 20 $aFundación Dr. Antonio Esteve.$bSymposium$n(4th :$d1990 :$cSon Vida, Spain)
245 14 $aThe clinical pharmacology of biotechnology products :$bproceedings of the Esteve Foundation Symposium IV, Son Vida, Mallorca, 7-10 October 1990 /$ceditor, M.M. Reidenberg.
260 0 $aAmsterdam ;$aNew York :$bExcerpta Medica ;$aNew York, NY, USA :$bSole distributors for the USA and Canada, Elsevier Science Pub. Co.,$c1991.
300 $axv, 331 p. :$bill. ;$c25 cm.
440 0 $aInternational congress series ;$vno. 944
440 0 $aEsteve Foundation symposia ;$vvol. 4
504 $aIncludes bibliographical references and indexes.
650 0 $aProteins$xTherapeutic use$xTesting$xCongresses.
650 0 $aPeptides$xTherapeutic use$xTesting$xCongresses.
650 0 $aBiological products$xTherapeutic use$xTesting$xCongresses.
650 0 $aPharmaceutical biotechnology$xTechnique$xCongresses.
650 2 $aBiological Products$xpharmacology$xcongresses.
650 2 $aBiological Products$xtherapeutic use$xcongresses.
650 2 $aBiotechnology$xcongresses.
700 10 $aReidenberg, Marcus M.,$d1934-